Popular Articles
Natural Remedies

Preimplantation Genetic Diagnosis May Pose Neurological Risks
Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. However, a new long-term analysis of PGD in mice suggests that this procedure may increase risks of weight gain and memory decline in adulthood.
generic viagra online
Plexxikon Announces PLX4032 Phase 1 Data Showing Objective Responses In Metastatic Melanoma Patients
Plexxikon Inc. today announced preliminary data from a Phase 1 clinical study investigating PLX4032 (R7204). PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in most melanomas and about eight percent of all solid tumors. In patients whose cancer harbors this mutation and who were treated with therapeutic doses of PLX4032, tumor shrinkage and extended progression-free survival have been observed. Currently, two extension studies are being conducted in mutation-positive melanoma and colorectal cancer patients. Following the initial positive findings announced today, larger clinical trials to support a registration program for product approval are targeted to start later in 2009. Plexxikon and Roche are co-developing PLX4032 under their 2006 license and collaboration agreement.
News of the day
Roche To Offer Developing Countries Discounted Tamiflu
The pharmaceutical company Roche on Wednesday announced a program to help ensure developing countries have access to its antiviral Tamiflu, for "the management of a novel influenza strain defined by the WHO as having significant and current pandemic potential," Reuters reports (Egenter, 7/1). The program will make Tamiflu, which has been shown to be effective against the H1N1 (swine flu) virus, available to developing countries for "half the price normally charged," Dow Jones Newswires/Wall Street Journal reports (Mengewein, 7/1).
Cardiovascular

Potential Prenatal Origins For Poor Sleep In Children

A study, "Prenatal Origins of Poor Sleep in Children," in the Aug.1 issue of the journal SLEEP found that alcohol consumption during pregnancy and small body size at birth predict poorer sleep and higher risk of sleep disturbances in 8-year-old children born at term. Findings are clinically significant, as poor sleep and sleep disturbances in children are associated with obesity, depressive symptoms, attention deficit hyperactivity disorder, and poor neurobehavioral functioning. Results indicate that children exposed prenatally to alcohol were 2.5 times more likely to have a short sleep duration of 7.7 hours or less and 3.6 times more likely to have a low sleep efficiency of 77.2 percent or less across all nights, independent of body size at birth and current maternal alcohol use. Smaller body size at birth also was associated with poorer sleep and with a higher risk for clinically significant sleep disturbances among children born at term. More specifically, lower weight and shorter length at birth were associated with lower sleep efficiency, and a lower ponderal index (an indicator of fetal growth status) was associated with the presence of sleep disturbances. In addition, children with short sleep duration were more likely to have been born via Caesarean section than were children sleeping longer (23.1 percent versus 8.4 percent respectively). According to principal investigator Katri Rç¤ikkç¶nen, PhD, in the department of psychology at the University of Helsinki, Finland, even low levels of weekly prenatal exposure to alcohol have adverse effects on sleep quantity and quality during childhood. "The results were in accordance with the fetal origins of health and disease hypothesis and the many studies that have shown that adverse fetal environment may have lifelong influences on health and behavior," said Rç¤ikkç¶nen. "However, this is among the few studies that have reported associations between birth variables and sleep quality and quantity among an otherwise healthy population of children." The epidemiologic cohort study obtained data from 289 children born at term (from 37 to 42 weeks of gestation) between March and November 1998. Sleep duration and sleep efficiency (actual sleep time divided by the time in bed) were measured objectively by actigraphy at 8 years of age for an average of 7.1 days. Parents completed the Sleep Disturbance Scale for Children to report sleep problems and sleep disorder symptoms such as bedtime resistance and sleep disordered breathing. Results show that the odds for low sleep efficiency increased by 70 percent for every standard deviation decrease in weight at birth and by more than 200 percent for every decrease in length. For every standard deviation decrease in ponderal index at birth, the risk of parent-reported sleep disorders increased by 40 percent. Associations were not confounded by sex, gestational length, prenatal and perinatal complications, body mass index (BMI) at eight years of age, asthma, allergies or parental socioeconomic status. The authors report that small body size at birth may function as a crude marker of disturbances in the fetal environment, and it is associated with prematurity, intrauterine growth retardation, prenatal alcohol exposure and poorer sleep quality in children and young adults. Results demonstrate that among children born healthy and at full-term, a linear relationship exists between smaller body size at birth and poorer sleep quality eight years from birth. Kelly Wagner American Academy of Sleep Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):